Although this is the first report of ROS1-GOPC fusion in HAS, database analysis highlights the previously unknown frequency of ROS1 and GOPC molecular alterations in soft tissue sarcomas and hepatic cancers. This evidence concerns the gene ROS1 and soft tissue sarcoma.